Agios Pharm (AGIO) — Working Capital to Net Assets Ratio
Agios Pharm (AGIO) has a Working Capital to Net Assets ratio of 70.0% as of March 2026. Working capital of $776.00 Million (current assets of $834.84 Million minus current liabilities of $58.84 Million) is measured against net assets of $1.11 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See AGIO equity financing ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Agios Pharm Working Capital to Net Assets (2011–2025)
This chart shows how Agios Pharm's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the ratio stands at 70.0%, reflecting working capital of $776.00 Million against net assets of $1.11 Billion USD. Check Agios Pharm (AGIO) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Agios Pharm (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Agios Pharm from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Agios Pharm stock valuation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 72.1% | $859.85 Million | $1.19 Billion | $942.05 Million | $82.21 Million | ▲ +14.7 pp |
| 2024 | 57.4% | $884.44 Million | $1.54 Billion | $965.60 Million | $81.16 Million | ▼ -37.0 pp |
| 2023 | 94.4% | $765.88 Million | $811.02 Million | $833.84 Million | $67.95 Million | ▲ +24.5 pp |
| 2022 | 70.0% | $770.14 Million | $1.10 Billion | $832.77 Million | $62.63 Million | ▼ -7.8 pp |
| 2021 | 77.7% | $1.00 Billion | $1.29 Billion | $1.06 Billion | $59.83 Million | ▼ -58.0 pp |
| 2020 | 135.7% | $542.28 Million | $399.50 Million | $636.68 Million | $94.39 Million | ▲ +54.7 pp |
| 2019 | 81.0% | $518.82 Million | $640.53 Million | $611.70 Million | $92.89 Million | ▲ +5.3 pp |
| 2018 | 75.7% | $520.28 Million | $687.54 Million | $613.78 Million | $93.50 Million | ▼ -17.6 pp |
| 2017 | 93.3% | $350.32 Million | $375.50 Million | $445.26 Million | $94.94 Million | ▼ -38.2 pp |
| 2016 | 131.5% | $471.46 Million | $358.59 Million | $559.89 Million | $88.43 Million | ▲ +49.1 pp |
| 2015 | 82.4% | $284.44 Million | $345.12 Million | $337.33 Million | $52.89 Million | ▲ +12.1 pp |
| 2014 | 70.3% | $298.46 Million | $424.37 Million | $359.55 Million | $61.09 Million | ▼ -30.7 pp |
| 2013 | 101.0% | $132.82 Million | $131.48 Million | $169.75 Million | $36.93 Million | ▼ -115.5 pp |
| 2012 | 216.5% | $95.03 Million | $43.90 Million | $130.14 Million | $35.11 Million | ▼ -9.1 pp |
| 2011 | 225.6% | $142.43 Million | $63.14 Million | $190.59 Million | $48.16 Million | — |